Community Funding Opportunities

Health Services Research on Minority Health & Health Disparities (R21)

Due Date: 01-09-2017
The purpose of this FOA is to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the health care system-level as well as within clinical settings. R01 also available

State Physical Activity & Nutrition Program

Due Date: 06-14-2018
The program will fund up to 15 state health departments to work with state and local partners that support communities to improve nutrition and to support safe and accessible physical activity. This five-year program provides state health departments the support and flexibility to work on systems at the state and local levels to implement evidence-based strategies and to leverage resources from multiple stakeholders and sectors (e.g., agriculture, transportation, education, business, commerce, housing) to improve the nutrition and physical activity status of Americans.

Community Facilities Direct Loan & Grant Program

Due Date: 06-15-2018
This program provides affordable funding to develop essential community facilities in rural areas. An essential community facility is defined as a facility that provides an essential service to the local community for the orderly development of the community in a primarily rural area, and does not include private, commercial, or business undertakings.

Southeast Rural Community Assistance Project Loan Fund

Due Date: 11-16-2017
The fund provides low-interest loans to low-income rural communities for predevelopment costs, system upgrades, and new construction of water and wastewater services and facilities. Loans are also available for housing and community development.

Buffett Family Foundation Pledged $90 Million to Aid Young Women of Color

The money will be deployed by the NoVo Foundation via three streams to fund: 1) community-based organizations¿ budget line items on continuing operations; 2) organizations and efforts in the southeastern U.S. in concert with a yet-undetermined regional partner. This money will also be used to form new organizations necessary to affect change and to fund individual efforts that may exist outside of established organizations; 3) broader concerns on a national level, including research organizations and policy change measures.

Breast Health Outreach Grants

The Avon Breast Health Outreach Program (BHOP) provides grants to nonprofit organizations to conduct outreach, provide education on breast health and breast cancer screening, link medically underserved women to care providers and clinical screening services, and help navigate patients through any necessary follow-up care.

Discovery Funding Opportunities

Innovative research award

Due Date: 05-01-2018
The Innovative Research Award provides independent academic investigators with the funding they need to pursue ideas that could lead to important breakthroughs in discovering new treatments and, one day, a cure for rheumatic diseases.

Physician-Scientist Research Award for Early Stage Investigators (R01 - clinical trial optional)

Due Date: 05-04-2018
The award is intended to support the independence of physician-scientist faculty committed to academic careers in heart, lung, and blood diseases and sleep disorders research, and related implementation science.

Bioengineering Research Partnerships

Due Date: 05-08-2018
The goal of a Bioengineering Research Partnership (BRP) is to drive the development and speed the adoption of promising tools and technologies that can address important biomedical problems for which insufficient or no solutions exist. The use of engineering principles is encouraged to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need. A synergistic partnership between engineering and the life, physical, and computational sciences is also encouraged, where the unique skills of each discipline combine to enhance our understanding of life science processes or the practice of medicine.

Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death & Survival (CBDS)] (U01 Clinical Trial Not Allowed)

Due Date: 05-10-2018
This FOA requests applications to explore human pancreatic tissues for the discovery of early biomarkers of T1D pathogenesis, the description of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the development of clinical diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification of therapeutic targets for the development of preventative or early treatment strategies.

Development & Integration of Novel Components for Open & Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional)

Due Date: 05-10-2018
This FOA encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective open- and closed-loop glucose control systems. Proposed research should tackle important obstacles at the level of sensing, hormone formulation and delivery, self-management decision support systems, and/or design of automated controllers/algorithms able to manage an integrated platform.

Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death & Survival (CBDS)] (U01 Clinical Trial Not Allowed)

Due Date: 05-10-2018
This FOA requests applications to explore human pancreatic tissues for the discovery of early biomarkers of T1D pathogenesis, the description of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the development of clinical diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification of therapeutic targets for the development of preventative or early treatment strategies.

Development of New Technologies & Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)

Due Date: 05-10-2018
This FOA encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for T1D. The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment.

Data Standards for Clinical Research & Drug Development (U24)

Due Date: 05-15-2018
The FDA Center for Drug Evaluation and Research is encouraging applications for projects to expedite development of data standards and terminologies to support human drug development and evaluation. The primary objective is to support research and the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics.

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording & Modulation in the Nervous System (U01-Clinical Trials Not Allowed)

Due Date: 05-15-2018
This FOA seeks applications for the optimization of existing and emerging technologies and approaches that have potential to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and temporal scales, in any region and throughout the entire depth of the brain.

Pilot & feasibility clinical research grants in kidney diseases (R21 clinical trial optional)

Due Date: 05-16-2018
This FOA is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions that are potentially of high clinical and public health impact.

Strategies to increase delivery of guideline-based care to populations with health disparities (R01 clinical trial optional)

Due Date: 05-18-2018
This FOA invites applications to conduct innovative and feasible studies to test strategies to accelerate the adoption of guideline-based recommendations into clinical practice among populations with health disparities.

Investigator-initiated genomic medicine research (R01 and R21)

Due Date: 05-20-2018
This opportunity supports research opportunities that will advance our understanding of, and the implementation of, the use of genomic information about an individual to inform clinical care, and the health outcomes of that clinical use.

PCORI Upcoming Research Funding Opportunities

Due Date: 05-21-2018
The next cycle of PCORI research funding opportunities will open on June 1. The cycle will include three opportunities, one on improving methods for conducting patient-centered outcomes research, a second for the implementation of PCORI-funded patient-centered outcomes research results, and a third looking for projects that fit within our five priority areas for research.

Smart & Connected Health: Connecting Data, People, and Systems

Due Date: 05-22-2018
The goal of the interagency program is to accelerate the development and integration of innovative computer and information science and engineering approaches to support the transformation of health and medicine.

Clinical research scholars program award

Due Date: 06-22-2018
This award will enable outstanding early career pediatricians and internists to enhance their clinical research proficiency and to develop the necessary clinical research capabilities to become independent investigators who formulate and lead multi-center, clinical research studies.

Bridge to success award for early career investigators

Due Date: 05-23-2018
The awards are designed to provide `bridge¿ funding to promising early-career sleep scientists who have applied for a career development award such as a K-award.

Partnerships between Science & Engineering Fields & the NSF TRIPODS Institutes

Due Date: 05-29-2018
The National Science Foundation's (NSF's) Directorates for Computer & Information Science & Engineering (CISE) and Mathematical & Physical Sciences (MPS) recently launched the Transdisciplinary Research in Principles of Data Science (TRIPODS) Phase I program with the goal of promoting long-term, interdisciplinary research and training activities that engage theoretical computer scientists, statisticians, and mathematicians in developing the theoretical foundations of data science.

Shared Instrumentation for Animal Research (SIFAR) Grant Program

Due Date: 05-31-2018
The program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH.

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

Due Date: 05-31-2018
The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, or clinical areas of biomedical/behavioral research.

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

Due Date: 05-31-2018
The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, or clinical areas of biomedical and bio-behavioral research.

Georgia Center for Diabetes Translation Research Small Grant Awards (GCDTR-03)

Due Date: 05-31-2018
The Georgia Center for Diabetes Translation Research (Georgia CDTR) is a collaboration of Emory University, Georgia Tech, and Morehouse School of Medicine, with funding provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and interinstitutional partners. The mission of the center is to facilitate and grow diabetes translation research at Emory, its partner institutions, and regionally. In alignment with this mission, this is a solicitation for small grant proposals that focus on Type II translation research in diabetes care and prevention.

Exploration of HL7 FHIR Standards for Clinical Research & Post-market Surveillance

Due Date: 06-11-2018
The FDA Center for Drug Evaluation and Research (CDER) is encouraging applications to explore the development of HL7 Fast Healthcare Interoperability Resources (FHIR) standards to address healthcare and clinical research information exchange.

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Due Date: 06-19-2018
This FOA represents the continuation of an NCI program to enhance the diversity of the pool of the cancer research workforce by recruiting and supporting eligible junior investigators and Early Stage Investigators from groups that have been shown to be nationally underrepresented in the biomedical, behavioral, clinical, and social sciences. This opportunity will also provide a bridge to investigators who have completed their research training and may need extra time to develop a larger research project grant application.

Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed)

Due Date: 06-20-2018
This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum.

2019 Vilcek Prizes for Creative Promise in Biomedical Science

Due Date: 06-11-2018
The Creative Promise Prizes were established in 2009 to honor emerging immigrant professionals who have demonstrated significant accomplishments early in their careers.

Technologies for healthy independent living for heart, lung, blood, & sleep disorders (R43- clinical trial not allowed)

Due Date: 06-11-2018
This FOA seeks applications for the design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for older adults with a chronic heart, lung, blood, or sleep condition.

Technologies for Healthy Independent Living for Heart, Lung, Blood, & Sleep Disorders (R43 - Clinical Trial Not Allowed)

Due Date: 06-11-2018
This FOA seeks applications for the design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for older adults with a chronic heart, lung, blood, or sleep (HLBS) condition. These technologies may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living for aging adults with HLBS conditions.

Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, & Blood Diseases & Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)

Due Date: 06-14-2018
This FOA seeks applications that propose to develop and test T4 implementation strategies to identify facilitators and overcome barriers in the adaptation, integration, scale-up, and sustainability of proven-effective interventions and guidelines for preventing and/or managing heart, lung, and blood diseases and/or sleep disorders. The proposed implementation strategies must be adaptable and responsive to community needs and contexts, and must account for cultural and organizational factors.

Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)

Due Date: 06-20-2018
The RIVER program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts.

NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)

Due Date: 06-20-2018
The award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers, and who plan to make a long-term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders.

Image-guided Drug Delivery (R01 Clinical Trial Optional)

Due Date: 06-21-2018
This FOA will support innovative research projects that are focused on image-guided drug delivery, including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response. It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.

Autoimmunity Centers of Excellence (ACE), Clinical Research Program (UM1 Clinical Trial Required)

Due Date: 06-22-2018
The ACE program, a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases, was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research.

Improving Patient Adherence to Treatment & Prevention Regimens to Promote Health (R01 and R21 Clinical Trial Optional)

Due Date: 06-25-2018
This FOA is issued by the NIH Adherence Network through the OBSSR with participation from multiple NIH Institutes and Centers. This FOA calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes. Applications may address healthcare regimen initiation, implementation, and/or persistence by patients.

Addressing health disparities in NIDDK diseases (R01)

Due Date: 06-25-2018
This FOA invites research projects to improve understanding of the causes of high priority diseases in the U.S. and reducing/eliminating health disparities. Research is encouraged in the following high priority diseases within the scientific mission areas of the NIDDK: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; sickle cell disease, specifically, studies in complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; hematologic diseases, including studies in abnormal hemoglobin synthesis; metabolic diseases; gastrointestinal, hepatic, and renal complications from infection with HIV.

National Centers for Translational Research in Reproduction & Infertility [NCTRI] (P50-Clinical Trial Optional)

Due Date: 06-29-2018
For the purpose of this FOA, reproductive health includes both fertility/infertility and gynecological health. These centers provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in these scientific areas.

Defense University Research Instrumentation Program

Due Date: 07-06-2018
This announcement seeks proposals from universities to purchase equipment and instrumentation in support of research in areas of interest to the DOD. A central purpose of the program is to provide equipment and instrumentation to enhance research-related education in areas of interest and priority to the DOD.

Cutting Edge Informatics Tools for Illuminating the Druggable Genome (IDG) (U01 Clinical Trial Not Allowed)

Due Date: 07-09-2018
The IDG consortium's purpose is to facilitate the unveiling of the functions of selected understudied proteins in the Druggable Genome using experimental and informatics approaches. Currently, this research consortium is composed of multiple Data and Resource Generation Centers (DRGCs), a Knowledge Management Center (KMC), and a Resource Dissemination and Outreach Center (RDOC). The purpose of this specific FOA is to solicit applications to build a set of Cutting Edge Informatics Tools (CEITs) that will augment the capability of the KMC as well as the broader IDG Consortium.

Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)

Due Date: 07-10-2018
This opportunity is intended to fund collaborative projects that bring new expertise and innovative approaches to enhance the value of major ongoing clinical research projects.

Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)

Due Date: 07-10-2018
This FOA will support research to test approaches in the healthcare setting to using Patient-Reported Outcomes (PROs) as tools to enhance patient-centered treatment and improve outcomes in individuals with type 1 diabetes.

Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)

Due Date: 07-10-2018
This FOA seeks applications for clinical trials testing interventions targeting diabetes distress in individuals with T1D and/or their caregivers, with the goal of understanding whether lowering diabetes distress will improve glycemic control and quality of life.

Elucidating the Effect of Glycemic Excursions on Patient Well-being & Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)

Due Date: 07-10-2018
This FOA encourages applications from institutions/organizations proposing research on the use of current and emerging technologies for monitoring of blood glucose levels to capture the relationship between blood glucose excursions, perception of wellbeing, and cognitive status in people with T1D.

Mass Spectrometric Assays for the Reliable & Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)

Due Date: 07-10-2018
The proposed assays should be highly reproducible, easily transferable to other laboratories, easy to multiplex, and validated in human plasma or serum.

Examining diversity, recruitment, & retention in aging research (R24 clinical trial not allowed)

Due Date: 07-24-2018
This FOA encourages collaborative teams to target gaps in methods and outcomes regarding research participant recruitment and retention.

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

Due Date: 07-25-2018
The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.

Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)

Due Date: 12-06-2018
This FOA encourages applications from integrative teams and individual investigators for projects to determine the mechanisms underlying the contribution of these risk-associated genes and their variants for Type 1 Diabetes (T1D). The purpose is to accelerate the discovery of function of the causal genes and variants that influence the risk for disease.

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03-Clinical Trial Not Allowed)

Due Date: 06-15-2018
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotype data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.

FY18 DOD Office of the Congressionally Directed Medical Research Programs (CDMRP) Pre-Announcements

Due Date: 04-09-2018
The CDMRP is providing information to allow investigators time to plan and develop ideas for submission to anticipated FY18 funding opportunities for ALS, MS, breast and ovarian cancers, and bone marrow failure research.

Biomarkers: Bridging Pediatric & Adult Therapeutics (R21)

This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)

Due Date: 12-31-2017
NIH is offering funding for administrative supplements to encourage and improve the diversity of the research workforce. This funding can help recruitment efforts and support for students, postdoctorates and eligible investigators from groups that have been underrepresented in health-related research.

Research on the Health of Transgender & Gender Nonconforming Populations (R01)

Due Date: 12-29-2017
This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Society of General Internal Medicine (SGIM) Founder's Grants

The grant will support research by a junior investigator. Applicants are encouraged to consider using the SGIM Research Dataset Compendium for their proposed research projects. This resource provides information about a number of public use datasets and provides opportunities from investigators to get mentoring and one-time consultation from senior SGIM members who are experienced in accessing and using the datasets.

NIA Academic Leadership Career Award (K07)

The objective of the award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

NIH Grants on Primary Immunodeficiency Diseases (R03/R21)

This FOA will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.

NIH Commons Credits Model

The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.

Advancing the Science of Geriatric Palliative Care (R01 & R21)

This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available

RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.

Ethical, Legal, & Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Small Grants for Secondary Analyses of Existing Data Sets & Stored Biospecimens (R03)

This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.

NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 and UG3/UH3)

The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.

Quick Wins

Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.

2019 NIH Director's Early Independence Awards

Due Date: 09-27-2018
The NIH Common Fund announces FY 2019 funding opportunity for the NIH Director's Early Independence Awards in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.

Training Funding Opportunities

Early- & Mid-Career Faculty Encouraged to Contact NIH to Express Interest in Next Generation Research Initiative

Due Date: 12-04-2017
The initiative will allocate approximately $210 million in FY2017 and an additional $210 million each year for four years to support additional meritorious early-stage and mid-career investigators. This amount will ramp up over five years to reach approximately $1.1 billion per year.

Transition to Independent Environmental Health Research (TIEHR) Career Award

Due Date: 01-15-2018
The award is a three-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences.

National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)

Due Date: 01-15-2018
The goal of the program is to develop a diverse pool of well-trained scientists available to address the Nation's biomedical research agenda. Specifically, this FOA provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical graduate training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise.

http://r20.rs6.net/tn.jsp?f=001GB0on3Cs9GYNa-87bvMrpo369IqntX90HLLvCkzt37lrUocgDEKHGG4KhRjjJufo1i_s43qzz2g7hMJ0Cobuoy3xMHWaQHDLxznQq8COe7kPjwPBXNxbZEYCfZOia7AKvn45GjKh-jk2tA7QwjVIM25O_P0-HvNc_wsrBziU84jTqeGMii0wrAZuldK5icrsJi2mwE268Nk=&c=cLmq-vyNJydN-aS2ef7JmzlW9MlmV_bH3c5O2ou3GBL0fPvjYWyqAQ==&ch=5EpYkulaPMUPAiPqnGUi5jaGsdDj_2DvleoUMUUHZ2xbMhhJgCSm1Q==

Due Date: 01-15-2018
The award is designed to enhance the participation of highly trained early career investigators from underrepresented groups in neuroscience research. This opportunity provides postdoctoral fellows from underrepresented groups with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position.

National Institute on Aging Grantee to Host Expense Covered Training for Early Career Investigators

Due Date: 05-01-2018
The Stanford Center on Longevity and Duke Center for Interdisciplinary Decision Science are inviting applications from early career social scientists to attend a two-day training workshop at Stanford University on September 10-11. Supported by a grant from the National Institute on Aging, this workshop will focus on strategies and tools for academic researchers to collaborate with private sector companies on applied research problems and interventions related to everyday decision making and behavior.

Clinical research scholars program award

Due Date: 06-22-2018
This award will enable outstanding early career pediatricians and internists to enhance their clinical research proficiency and to develop the necessary clinical research capabilities to become independent investigators who formulate and lead multi-center, clinical research studies.

Training Modules to Enhance the Rigor & Reproducibility of Biomedical Research

Due Date: 06-29-2018
The over-arching goals of the NIH R25 program are to: (1) complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs; (2) enhance the diversity of the biomedical, behavioral, and clinical research workforce; (3) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral, and clinical sciences; and (4) foster a better understanding of biomedical, behavioral, and clinical research and its implications.

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)

Due Date: 08-31-2018
This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases.

NIDA Research Education Program for Clinical Researchers & Clinicians (R25 Clinical Trial Optional)

Due Date: 09-20-2018
The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs. This FOA is intended to support research education activities that enhance the knowledge of substance abuse and addiction research.

Commercialization Funding Opportunities

What Tech Startups Are Coke Worthy?

With a 4% Atlanta-based soft drink giant, Coca-Cola, just announced The Bridge, a six-month commercialization program to develop early-stage partnerships.

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional)

Due Date: 08-15-2018
This FOA solicits Small Business Innovation Research (SBIR) applications from small business concerns that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage.

Upcoming Events

    View All Events

    Funding News

    Community

    Georgia CTSA Pilot Grants Program

    For over 10 years the Georgia CTSA Pilot Grants program has distributed grant funding to support one to two year pilot projects that advance and transform laboratory, clinic, and community observations into interventions that improve public and...

    Discovery

    CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

    A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....